BPG is committed to discovery and dissemination of knowledge
Review
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. May 27, 2026; 18(5): 119105
Published online May 27, 2026. doi: 10.4240/wjgs.v18.i5.119105
Table 6 Topical synthetic hemostatic agents
Sub-class
Works on
Feature
Limitation
Ref.
Cyanoacrylates (Octyl-2, Butyl-2)Moisture-induced polymerization forming tissue adhesionRapid sealant, waterproof, sutureless closure; used for skin wounds and variceal embolizationEmbolic risk if intravascular; toxic degradation products; unsuitable for mucosa, joints, avulsed tissue, or vascular anastomoses[142-144]
Microporous polysaccharide hemospheresAbsorb fluid to concentrate platelets and clotting proteinsAccelerates endogenous clotting; reduces time to hemostasisIneffective in severe coagulopathy; limited efficacy in high-pressure bleeding[145]
PEG hydrogel (CoSeal)Cross-linked hydrogel sealing tissue planesSealant and anti-adhesion barrier; non-exothermic, low inflammation; reduces pericardial adhesionsSwelling may compress adjacent structures; poor adhesion to renal parenchyma[146]
Glutaraldehyde cross-linked albumin (BioGlue)Protein cross-linking forming rigid adhesive scaffoldStrong adhesion to tissue and synthetic grafts; useful in vascular/cardiac surgeryTissue toxicity, stenosis risk; avoided in young patients[147-149]
Synthetic hemostatic nanomoleculesCationic interaction enhances platelet aggregationRapid hemostasis in experimental liver and trauma modelsPredominantly preclinical; limited human safety data[149-151]


Write to the Help Desk